ConductScience.org, home

Paper42528343

A Retrospective Study Examining Predictors of Treatment Response in Over 1,300 Children and Adolescents with Attention-deficit Hyperactivity Disorder.

Gul MK and 3 others. Clin Psychopharmacol Neurosci, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. A Retrospective Study Examining Predictors of Treatment Response in Over 1,300 Children and Adolescents with Attention-deficit Hyperactivity Disorder. Papers, record 42528343. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42528343

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Retrospective Study Examining Predictors of Treatment Response in Over 1,300 Children and Adolescents with Attention-deficit Hyperactivity Disorder.
PubMed
Journal
Clin Psychopharmacol Neurosci
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gul MKMelike Kevserhttps://orcid.org/0000-0002-0907-4503
2Hudayioglu BBukrenurhttps://orcid.org/0009-0008-4035-3704
3Demirci EEsrahttps://orcid.org/0000-0002-8424-4947
4Ozmen SSevgihttps://orcid.org/0000-0002-7545-2824

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119318988Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study.J Am Acad Child Adolesc Psychiatry2009https://conductscience.org/library/papers/19318988PubMed
238519608Continuity of mental disorders in children with chronic physical illness.Eur Child Adolesc Psychiatry2024https://conductscience.org/library/papers/38519608PubMed
320482957Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders.Can J Psychiatry2010https://conductscience.org/library/papers/20482957PubMed
437243373Predicting the Response of Children and Adolescents With ADHD to Methylphenidate: A Systematic Review.J Atten Disord2023https://conductscience.org/library/papers/37243373PubMed
518714205The impact of medical comorbidity on mental health and functional health outcomes among children with anxiety disorders.J Dev Behav Pediatr2008https://conductscience.org/library/papers/18714205PubMed
6670589Normative data on revised Conners Parent and Teacher Rating Scales.J Abnorm Child Psychol1978https://conductscience.org/library/papers/670589PubMed
735884035Psychological and Psychiatric Comorbidities in Youth with Serious Physical Illness.Children (Basel)2022https://conductscience.org/library/papers/35884035PubMed
817144907Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder.Behav Brain Funct2006https://conductscience.org/library/papers/17144907PubMed
936306807
Efficacy and safety of methylphenidate and behavioural parent training for children aged 3-5 years with attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled, and sham behavioural parent training-controlled trial.
Lancet Child Adolesc Health2022https://conductscience.org/library/papers/36306807PubMed
1034356141Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder.Brain Sci2021https://conductscience.org/library/papers/34356141PubMed
1135832601Genome Guided Personalized Drug Therapy in Attention Deficit Hyperactivity Disorder.Front Psychiatry2022https://conductscience.org/library/papers/35832601PubMed
1221508864
Do phenotypic characteristics, parental psychopathology, family functioning, and environmental stressors have a role in the response to methylphenidate in children with attention-deficit/hyperactivity disorder? A naturalistic study from a developing country.
J Clin Psychopharmacol2011https://conductscience.org/library/papers/21508864PubMed
138714323Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study.J Am Acad Child Adolesc Psychiatry1996https://conductscience.org/library/papers/8714323PubMed
1424703228
Predictors of pharmacological treatment outcomes with atomoxetine or methylphenidate in patients with attention-deficit/hyperactivity disorder from China, Egypt, Lebanon, Russian Federation, Taiwan, and United Arab Emirates.
Int J Clin Pract2014https://conductscience.org/library/papers/24703228PubMed
1517364268[Validation of the Turkish versions of the short-form Conners' teacher and parent rating scales].Turk Psikiyatri Derg2007https://conductscience.org/library/papers/17364268PubMed
1624994874Persistence of Parent-Reported ADHD Symptoms From Childhood Through Adolescence in a Community Sample.J Atten Disord2016https://conductscience.org/library/papers/24994874PubMed
1718281409Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.Am J Psychiatry2008https://conductscience.org/library/papers/18281409PubMed
1821422081A double-blind, placebo-controlled study of atomoxetine in young children with ADHD.Pediatrics2011https://conductscience.org/library/papers/21422081PubMed
1928258319Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison.Eur Child Adolesc Psychiatry2017https://conductscience.org/library/papers/28258319PubMed
2025612927Persistence and remission of ADHD during adulthood: a 7-year clinical follow-up study.Psychol Med2015https://conductscience.org/library/papers/25612927PubMed

See all 36 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42528343

GET https://conductscience.org/api/papers/v1/42528343/references?page=2